Literature DB >> 9598722

Myotonia congenita in northern Finland: an epidemiological and genetic study.

P Baumann1, V V Myllylä, J Leisti.   

Abstract

An epidemiological and genetic investigation of myotonia congenita was carried out in northern Finland. Altogether 58 patients were identified (of whom 54 lived in the study area) in 23 families, with a prevalence of 7.3 per 100000. The majority of the families originated from a sparsely populated area in western Lapland. The mean age at onset of the disease was 11 years with a range of 2 to 45 years. The mean time that had passed before verification of the clinical disease was 18 (SD 14) years. The sex ratio M/F was 2.2/1.0. Forty-seven cases were familial and 11 were sporadic. In six families/pedigrees the inheritance was compatible with autosomal recessive and in two families with autosomal dominant inheritance. In five additional families, in which autosomal recessive inheritance seemed most plausible, vertical transmission was also noticed. This could be explained either by consanguinity of the parents or by variant expression of the mutation(s) involved. Our results suggest that myotonia congenita is unusually frequent in northern Finland, most probably as a consequence of an enrichment of the gene mutation(s) in the population.

Entities:  

Mesh:

Year:  1998        PMID: 9598722      PMCID: PMC1051276          DOI: 10.1136/jmg.35.4.293

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

Review 1.  Hereditary diseases in Finland; rare flora in rare soul.

Authors:  R Norio; H R Nevanlinna; J Perheentupa
Journal:  Ann Clin Res       Date:  1973-06

Review 2.  Disease gene mapping in isolated human populations: the example of Finland.

Authors:  A de la Chapelle
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

3.  Quantification of muscle strength in recessive myotonia congenita.

Authors:  P Baumann; P Siira; H Vanharanta; V V Myllylä
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

4.  Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979).

Authors:  L Pinessi; L Bergamini; R Cantello; C Di Tizio
Journal:  Ital J Neurol Sci       Date:  1982-10

5.  Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia.

Authors:  C Meyer-Kleine; K Steinmeyer; K Ricker; T J Jentsch; M C Koch
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

6.  Myotonia congenita: quantitation of different aspects of motor performance.

Authors:  P Baumann; H Vanharanta; K Kauranen; V Myllylä
Journal:  Eur Neurol       Date:  1995       Impact factor: 1.710

  6 in total
  11 in total

1.  High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany.

Authors:  T Suominen; B Schoser; O Raheem; S Auvinen; M Walter; R Krahe; H Lochmüller; W Kress; B Udd
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

2.  Clinical Utility Gene Card for: autosomal dominant myotonia congenita (Thomsen Disease).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-04-26       Impact factor: 4.246

Review 3.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 4.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

Review 5.  Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.

Authors:  Jeffrey M Statland; Richard J Barohn
Journal:  Continuum (Minneap Minn)       Date:  2013-12

6.  Prevalence study of genetically defined skeletal muscle channelopathies in England.

Authors:  Alejandro Horga; Dipa L Raja Rayan; Emma Matthews; Richa Sud; Doreen Fialho; Siobhan C M Durran; James A Burge; Simona Portaro; Mary B Davis; Andrea Haworth; Michael G Hanna
Journal:  Neurology       Date:  2013-03-20       Impact factor: 9.910

Review 7.  Drug treatment for myotonia.

Authors:  J Trip; G Drost; B G M van Engelen; C G Faber
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

8.  Delay in diagnosis of muscle disorders depends on the subspecialty of the initially consulted physician.

Authors:  Simone Spuler; Andrea Stroux; Franziska Kuschel; Adelheid Kuhlmey; Friederike Kendel
Journal:  BMC Health Serv Res       Date:  2011-05-04       Impact factor: 2.655

9.  Moroccan consanguineous family with Becker myotonia and review.

Authors:  Ilham Ratbi; Siham Chafai Elalaoui; Adela Escudero; Yamina Kriouile; Jesus Molano; Abdelaziz Sefiani
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

Review 10.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.